IMNN: Imunon Inc

IMNN Nouvelles

• Investing 12:15 First patient dosed in IMUNON’s phase 3 ovarian cancer trial
• Investing 12:05 IMUNON announces 1-for-15 reverse stock split to maintain Nasdaq listing
• Investing 12:46 Imunon registers additional $4.5 million in shares under at-the-market program
• Investing 12:11 Imunon receives Nasdaq extension to maintain listing status
• Investing 21:50 Imunon receives Nasdaq exception to address listing deficiencies and amends stock plan
• Investing 21:20 Imunon shareholders approve increase in authorized shares and reverse split
• Investing 11:34 H.C. Wainwright reiterates buy rating on Imunon stock at $14 target
• Investing 12:13 IMUNON reports promising ovarian cancer therapy data at ESMO
• Investing 12:18 IMUNON reports durability data for COVID-19 vaccine alternative
• Investing 21:35 Imunon Inc. appoints new CFO following termination
• Investing 13:44 IMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12th
• Investing 12:12 IMNN-001 shows promise in ovarian cancer treatment
• Investing 20:40 Imunon Inc. Faces Nasdaq Delisting Over Compliance Issues
• Benzinga 09:44 Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - C3.ai (NYSE:AI), Actelis Networks (NASDAQ:ASNS)
• Benzinga 09:22 Why Box Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Brooge Energy (NASDAQ:BROG), Box (NYSE:BOX)
• Investing 20:30 U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.78%
• Investing 12:24 IMUNON Invited to Present  Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025
• Benzinga 10:30 US Stocks Likely To Open Higher After S&P 500's Four-Day Fall: 'Market Is Risk-Off,' Says Expert - Apple (NASDAQ:AAPL), AutoZone (NYSE:AZO)
• Investing 20:30 U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.61%
• Benzinga 16:10 Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook - Bicara Therapeutics (NASDAQ:BCAX), BloomZ (NASDAQ:BLMZ)
• Benzinga 15:10 Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook - Bicara Therapeutics (NASDAQ:BCAX), BloomZ (NASDAQ:BLMZ)
• Benzinga 14:22 Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results - Bicara Therapeutics (NASDAQ:BCAX), BloomZ (NASDAQ:BLMZ)
• Investing 13:13 Imunon shares soar on promising ovarian cancer trial results
• Investing 12:16 IMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian Cancer